Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced Non-small Cell Lung Cancer Patients (NSCLC)

NCT04912687 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT04912687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04912687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced Non-small Cell Lung Cancer Patients (NSCLC)
Lead sponsor
Institut Bergonié
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2022
Completion date
January 17, 2026
Enrollment
581 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, non small cell lung cancer